These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 7201699

  • 1. [Concentrically layered microconcrements in the renal medulla of nephrolithiasis patients. A contribution to the renal stone pathogenesis (author's transl)].
    Gusek W, Bode W, Matouschek E, Huber R.
    Urologe A; 1982 May; 21(3):137-41. PubMed ID: 7201699
    [Abstract] [Full Text] [Related]

  • 2. [Intrarenal calcium crystallization. An electron microscopy study].
    Hering F, Burschardt WG.
    Urologe A; 1986 Mar; 25(2):116-9. PubMed ID: 3716039
    [Abstract] [Full Text] [Related]

  • 3. Etiology of calcium oxalate nephrolithiasis in rats. I. Can this be a model for human stone formation?
    de Bruijn WC, Boevé ER, van Run PR, van Miert PP, de Water R, Romijn JC, Verkoelen CF, Cao LC, Schröder FH.
    Scanning Microsc; 1995 Mar; 9(1):103-14. PubMed ID: 8553009
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of formation of human calcium oxalate renal stones on Randall's plaque.
    Evan AP, Coe FL, Lingeman JE, Shao Y, Sommer AJ, Bledsoe SB, Anderson JC, Worcester EM.
    Anat Rec (Hoboken); 2007 Oct; 290(10):1315-23. PubMed ID: 17724713
    [Abstract] [Full Text] [Related]

  • 5. Etiology of calcium oxalate nephrolithiasis in rats. II. The role of the papilla in stone formation.
    de Bruijn WC, Boevé ER, van Run PR, van Miert PP, de Water R, Romijn JC, Verkoelen CF, Cao LC, van 't Noordende JM, Schrder FH.
    Scanning Microsc; 1995 Mar; 9(1):115-24; discussion 124-5. PubMed ID: 8553010
    [Abstract] [Full Text] [Related]

  • 6. Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones.
    Khan SR.
    Scanning Microsc; 1995 Mar; 9(1):89-100; discussion 100-1. PubMed ID: 8553028
    [Abstract] [Full Text] [Related]

  • 7. Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization.
    Evan AP, Coe FL, Rittling SR, Bledsoe SM, Shao Y, Lingeman JE, Worcester EM.
    Kidney Int; 2005 Jul; 68(1):145-54. PubMed ID: 15954903
    [Abstract] [Full Text] [Related]

  • 8. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
    Khan SR, Thamilselvan S.
    Mol Urol; 2000 Jul; 4(4):305-12. PubMed ID: 11156696
    [Abstract] [Full Text] [Related]

  • 9. Pathogenesis of renal calculi.
    Miller NL, Evan AP, Lingeman JE.
    Urol Clin North Am; 2007 Aug; 34(3):295-313. PubMed ID: 17678981
    [Abstract] [Full Text] [Related]

  • 10. [Diagnostic markers in calcium nephrolithiasis--current and traditional ideas with a new look].
    Hess B.
    Schweiz Med Wochenschr; 1995 Dec 26; 125(51-52):2460-70. PubMed ID: 8571096
    [Abstract] [Full Text] [Related]

  • 11. Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone.
    Evan AP, Lingeman JE, Coe FL, Worcester EM.
    Semin Nephrol; 2008 Mar 26; 28(2):111-9. PubMed ID: 18359392
    [Abstract] [Full Text] [Related]

  • 12. Origin and types of calcium oxalate monohydrate papillary renal calculi.
    Grases F, Costa-Bauzá A, Gomila I, Conte A.
    Urology; 2010 Dec 26; 76(6):1339-45. PubMed ID: 20466410
    [Abstract] [Full Text] [Related]

  • 13. Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients.
    Evan AP, Bledsoe S, Worcester EM, Coe FL, Lingeman JE, Bergsland KJ.
    Kidney Int; 2007 Dec 26; 72(12):1503-11. PubMed ID: 17898697
    [Abstract] [Full Text] [Related]

  • 14. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
    Thamilselvan S, Menon M.
    BJU Int; 2005 Jul 26; 96(1):117-26. PubMed ID: 15963133
    [Abstract] [Full Text] [Related]

  • 15. [Calcium nephrolithiasis and phosphate therapy. Long term study (65 cases) (author's transl)].
    Lagrue G, Hioco D, Kazandjian M, Cattaneo A, Cassagnol M.
    Sem Hop; 2005 Jul 26; 56(21-24):1043-8. PubMed ID: 6248982
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the pathology of interstitial plaque in human ICSF stone patients to NHERF-1 and THP-null mice.
    Evan AP, Weinman EJ, Wu XR, Lingeman JE, Worcester EM, Coe FL.
    Urol Res; 2010 Dec 26; 38(6):439-52. PubMed ID: 21063698
    [Abstract] [Full Text] [Related]

  • 17. [Idiopathic calcium oxalate urinary lithiasis: new physiopathological approaches].
    Berland Y.
    Nephrologie; 1999 Dec 26; 20(7):363-9. PubMed ID: 10642984
    [Abstract] [Full Text] [Related]

  • 18. The preventive effect of sodium pentosan polysulfate against renal stone formation in hyperoxaluric rats.
    Nakatani T, Ishii K, Yoneda Y, Kamikawa S, Kanazawa T, Sugimoto T, Osswald H.
    Urol Res; 2002 Oct 26; 30(5):329-35. PubMed ID: 12389123
    [Abstract] [Full Text] [Related]

  • 19. Renal papillary changes in patient with calcium oxalate lithiasis.
    Khan SR, Finlayson B, Hackett R.
    Urology; 1984 Feb 26; 23(2):194-9. PubMed ID: 6695491
    [Abstract] [Full Text] [Related]

  • 20. Crystals, Randall's plaques and renal stones: do bone and atherosclerosis teach us something?
    Gambaro G, D'Angelo A, Fabris A, Tosetto E, Anglani F, Lupo A.
    J Nephrol; 2004 Feb 26; 17(6):774-7. PubMed ID: 15593050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.